Temple Grandin: Thinking in pictures

V. Paradiz 2005 Elijah's Cup: A Family's Journey into the Community and Culture of High Functioning Autism and Asperger's Syndrome London., Jessica Kingsley

S. Shore 2001 Beyond the Wall — Personal Experiences with Autism and Asperger Syndrome. Shawnee Mission, Kansas., Autism Asperger Publishing

B. Trivedi 2005 pp. 36–40. Autistic and Pour, New Scientist, June 18,

L. Kanner 1971 112–145. Follow-up study of eleven autistic children originally reported in 1943. Journal of Autism and Childhood Schizophrenia, 1:

L. Kanner, A. Rodriguez, B. Ashender 1972 9–33. How far can autistic children go in matters of social adaptation? Journal of Autism and Childhood Schizophrenia, 2:

P. Szatmari, G. Bartolucci, S. Bond, S. Rich 1989 A follow-up study of high-functioning autistic children. Journal of Autism and Developmental Disorders, 19: 213–225.

Barrett R. P. C. Feinstein, Hole W. T. 1989 Effects of naloxone and naltrexone on self-injury: A double-blind placebo-controlled analysis. American Journal of Mental Retardation, 93: 644–651.

Bowden C. L. Brugger A. M. Swann A. C. Calabrese J. R. Janicak P. G. F. Petty, Dilsaver S. C. Davis J. M. Rush A. J. et al. Small J. G. 1994 Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Journal of the American Medical Association, 271: 908–924.

Cohen S. A. Fitzgerald R. J. Khan S. R. A. Khan 2004 The effect of a switch to ziprasidone (Geodon) in an adult population with autistic disorders: Chart review of naturalistic open label treatment. Journal of Clinical Psychiatry, 65: 110–113.

Comings E. D. 1990 Tourette Syndrome and human behavior. California., Hope, Duarte

Jr., Cook E. H. R. Rowlett, C. Jaseiskis, B. Leventhal 1992 Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 4:, 739–745.

J. Couzin 2004 Volatile chemistry: Children and antidepressants. Science, 305: 468–470.

Delong G. R. Teague L. A. Kaufman M. M. 1998 Effect of fluoxetine (Prozac) treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology, 40: 551–562.

et al. Dodman N. H. 1987 Investigation into the use of narcotic antagonists in the treatment of stereotypic behavior pattern (crib biting) in the horse. American Journal of Veterinary Research, 48: 311–319.

Donovan S. J. Stewart J. W. Nunes E. W. 2000 Divalproex treatment of youth with explosive temper and mood liability. A double-blind placebocontrolled crossover design. American Journal of Psychiatry, 157: 818–820.

Edwards J. G. Anderson L. 1999 Systematic review and guide to selective serotonin reuptake inhibitors. Drugs, 57: 507–533.

M. Fankhauser, Karumanchi V., M. German, A. Yates, Karumanchi S. D 1992 A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53, 3:, 77–82.

Fieve R. R. 1994 Prozac: Questions and answers for patients, family and physicians. New York., Avon

A. Gedye 1989 Episodic rage and aggression attributed to frontal lobe seizures. Journal of Mental Deficiency Research, 33: 369–379.

A. Gedye 1992 Anatomy of self-injurious, stereotypic, and aggressive movements: Evidence for involuntary explanation. Journal of Clinical Psychology, 48, 6:, 766–778.

C. Gillberg 1991 The treatment of epilepsy in autism. Journal of Autism and Developmental Disorders, 21: 61–77.

Gordon C. T. State R. C Nelson J. E. Hamburger S. D. Rapoport J. L. 1993 A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50: 441–447.

T. Grandin 1984 A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50: 441–447.

T. Grandin 1992 An inside view of autism.. (eds.), E. Schopler (eds.), G. B. Mesibov. High-functioning individuals with autism. New York, Plenum, pp. 105–126.

T. Grandin, M. Scariano 1986 An inside view of autism.. (eds.), E. Schopler (eds.), G. B. Mesibov. High-functioning individuals with autism. New York, Plenum, pp. 105–126.

P. Hardy M. 1989 National Conference of the Autism Society of America. Seattle, July 19–22, 1989 (personal communication).. Washington, Lecture with no published paper.

K. Horvath, Perman J. A. 2002 Autism and gastrointestinal symptoms. Current Gastroentorology Reports, 4: 251–258.

K. Jamison R. 1993 Touched with fire. New York., Free Press

Knivesberg A. M. Reichelt K. L. T. Hoien, M. Nodland 2002 A randomized controlled study of dietary intervention in autistic syndromes. Nutritional Neurosciences, 4: 251–261.

H. Kwon 2004 Tardive dykinesia in an autistic patient treatment with risperidone. American Journal of Psychiatry, 161: 757–758.

P. Lerman, T. Lerman-Sagie, S. Kivity 1991 Effect of early corticosteroid therapy for Landau-Kleffner syndrome. Developmental Medicine and Child Neurology, 33: 257–266.

L. Lewis 1998 Special Diets for Special Kids. Arlington, Texas., Future Horizons

Lewis L. S. 2005 Gf and Cf plain and simple. Autism Asperger Digest Magazine, Jan/Feb., pp. 10–11.

Lindsay R. L. Aman M. G. 2003 Pharmocologic therapies and treatment for autism. Pediatric Annals, 32: 671–676.

et al. A. Martin, L. Scahill, Anderson G. M. Aman M. 2004 Weight and leptin changes among risperidone treatment youths with autism: 6-month prospective data. American Journal of Psychiatry, 161: 1125–1127.

J. Martineau, C. Barthelemy, B. Garreau, G. Lelord 1985 Vitamin B6, magnesium and combined B6−Mg. Therapeutic effects in childhood autism. Biological Psychiatry, 20: 467–478.

J. Martineau, C. Barthelemy, G. Lelord 1986 Long-term effects of combined vitamin B6−magnesium administration in an autistic child. Biological Psychiatry, 21: 511–518.

Mathews A. W. Abboud A. L. 2005 FDA raises concerns about ADHD drugs. Wall Street Journal, June 29, pp. D1 and D5.

McClellan J. M. Werry J. S. 2003 Evidence based treatments in child and adolescent psychiatry. Journal of American Academy of Child and Adolescent Psychiatry. pp.

McDougle C. J. Kem D. L. Posey D. J. 2003 Core Series: Use of ziprasi-done for maladaptive symptoms in youths with autism. Journal of American Academy of Child and Adolescent Psychiatry, 41: 921–927.

McCracken J. T. J. McGough, B. Shah, P. Cronin, et al. D. Hong 2002 Risperdone in children with autism and serious behavioral problems. New England Journal of Medicine, 347: 314–321.

C. Millward, M. Ferrita, S. Calver, G. Connell-Jones 2004 Gluten and casein free diets. Cochrane Database Systems Review, 2: CD003498.

J. Panksepp, P. Lensing 1991 Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children. Journal of Autism and Developmental Disorders, 21, 2:, 135–140.

Plioplys A. V. 1994 Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Archives of Pediatrics and Adolescent Medicine, 148: 220–222.

D. Rapp 1991 Is this your child? Discovering and treating unrecognized allergies. New York., William Morrow

et al. Ratey J. J. 1987 Autism: The treatment of aggressive behaviors. Journal of Clinical Psychopharmacology 7, 1:, 35–41.

Richardson A. J. P. Montgomery 2005 The Oxford-Durham study — a randomized controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115: 1360–1366.

et al. R. Ricketts 1993 Fluoxetine treatment of severe self-injury in young adults with mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 4:, 865–869.